Anti-OATP1B1 antibody [EPR27070-49]
- BOND RX™ Validated
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal OATP1B1 antibody. Suitable for WB, IHC-P, Dot and reacts with Human, Transfected cell lysate - Human samples.
View Alternative Names
LST1, OATP1B1, OATP2, OATPC, SLC21A6, SLCO1B1, Solute carrier organic anion transporter family member 1B1, Liver-specific organic anion transporter 1, OATP-C, Organic anion transporter SLC21A6, Sodium-independent organic anion-transporting polypeptide 2, Solute carrier family 21 member 6, LST-1, OATP-2
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-OATP1B1 antibody [EPR27070-49] (AB312838)
Immunohistochemical analysis of paraffin-embedded Human hepatocellular tissue labeling OATP1B1 with ab312838 at 1/2000 (0.255 ug/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Positive staining on human hepatocellular carcinoma. The section was incubated with ab312838 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-OATP1B1 antibody [EPR27070-49] (AB312838)
Immunohistochemical analysis of paraffin-embedded Human liver tissue labeling OATP1B1 with ab312838 at 1/2000 (0.255 ug/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Positive staining on human liver. The section was incubated with ab312838 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins.
- WB
Supplier Data
Western blot - Anti-OATP1B1 antibody [EPR27070-49] (AB312838)
Blocking and diluting buffer and concentration : 5% NFDM/TBST Negative control : Human kidney, Human skeletal muscle (PMID : 10644574). The molecular weight observed is consistent with what has been described in the literature (PMID : 30970235, 16697742). Lane 1 lysate was prepared via the 1% SDS HOT lysis method, lanes 2-4 were prepared via RIPA lysis. In Western blot, anti-GAPDH antibody (ab181602) loading control staining at 1/200000 dilution. Exposure time : 10 seconds
All lanes:
Western blot - Anti-OATP1B1 antibody [EPR27070-49] (ab312838) at 1/1000 dilution
Lane 1:
Human liver tissue lysate at 20 µg
Lane 2:
Human liver cancer tissue lysate at 20 µg
Lane 3:
Human kidney tissue lysate at 20 µg
Lane 4:
Human skeletal muscle tissue lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 72 kDa,95 kDa
false
Exposure time: 10s
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-OATP1B1 antibody [EPR27070-49] (AB312838)
Immunohistochemical analysis of paraffin-embedded Human kidney tissue labeling OATP1B1 with ab312838 at 1/2000 (0.255 ug/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Negative control : no staining on human kidney. The section was incubated with ab312838 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins.
- Dot
Supplier Data
Dot Blot - Anti-OATP1B1 antibody [EPR27070-49] (AB312838)
Dot blot analysis of OATP1B1 using ab312838 at 1 : 1000 (0.51 ug/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1 : 100,000 dilution. Lane 1 : 293T cells transfected with a human OATPB3 expression vector containing a His-tag whole cell lysate 1 μg Lane 2 : 293T cells transfected with a human OATPB7 expression vector containing a His-tag whole cell lysate 100 ng Lane 3 : 293T cells transfected with a human OATPB1 expression vector containing a His-tag whole cell lysate 50 ng Exposure time : 15 sceonds Blocking and diluting buffer and concentration : 5% NFDM/TBST
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
OATP1B1 contributes prominently to drug metabolism and clearance. It actively transports diverse substrates including bile acids bilirubin and drugs such as statins. While not part of a larger complex OATP1B1 functions alongside other hepatic transporters to ensure efficient clearance and detoxification processes in the liver. The activity of OATP1B1 is fundamental for maintaining drug concentrations within therapeutic ranges thereby protecting against toxicity.
Pathways
OATP1B1 is part of the hepatic drug metabolic pathway and the bile acid synthesis pathway. It works in coordination with other transporters like OATP1B3 and NTCP which also mediate hepatic uptake of organic anions and bile acids. The interaction among these transporters regulates the systemic levels of endogenous compounds and the clearance of therapeutic drugs influencing their efficacy and safety profiles.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Associated Products
Alternative Version
Primary Antibodies
AB312839
Anti-OATP1B1 antibody [EPR27070-49] - BSA and Azide free
primary-antibodies
oatp1b1-antibody-epr27070-49-bsa-and-azide-free-ab312839
0
(0 reviews)
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com